Shaolong He
Overview
Explore the profile of Shaolong He including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
383
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang X, Jiang L, Zhang X, Peng J, Qian H, Huang L, et al.
Biomark Res
. 2024 Oct;
12(1):115.
PMID: 39379980
The role of the compromised immune microenvironment, including immune checkpoints, in myelodysplastic syndromes (MDS) has been identified as critical This study aimed to investigate the expression patterns of immune checkpoints,...
2.
Zhao J, Yang H, Ge J, Li L, Yao Q, He S, et al.
Blood Sci
. 2024 Mar;
6(2):e00184.
PMID: 38433987
Relapsed and refractory multiple myeloma (RRMM) and B-cell leukemia/lymphoma with extramedullary disease (EMD) have poor prognosis and high mortality, lack of effective therapeutic approaches. We reported for the first time...
3.
He S, Peng J, Yang X, Meng F, Huang L, Huang L, et al.
Front Biosci (Landmark Ed)
. 2023 Dec;
28(11):299.
PMID: 38062808
Background: Chimeric antigen receptor (CAR) T-cell therapy carries the risk of inducing severe and life-threatening toxicities such as cytokine release syndrome (CRS), neurotoxicity, and infection. Although CRS and infections have...
4.
Peng J, He S, Yang X, Huang L, Wei J
Crit Rev Oncol Hematol
. 2023 Oct;
192:104186.
PMID: 37863402
Plasmacytoid dendritic cells (pDCs) are a specific dendritic cell type stemming from the myeloid lineage. Clinically and pathologically, neoplasms associated with pDCs are classified as blastic plasmacytoid dendritic cell neoplasm...
5.
Zhang T, Tian W, Wei S, Lu X, An J, He S, et al.
Exp Hematol Oncol
. 2023 Jul;
12(1):66.
PMID: 37501090
The outbreak of coronavirus disease 2019 (COVID-19) posed an unprecedented challenge on public health systems. Despite the measures put in place to contain it, COVID-19 is likely to continue experiencing...
6.
Chen X, Xiao J, Wang X, Lu X, An J, Zhao J, et al.
Ann Hematol
. 2023 Jul;
102(10):2933-2942.
PMID: 37421505
Rhino-orbital-cerebral mucormycosis (ROCM), which is an acute fatal infectious disease with a high mortality rate, is increasingly being diagnosed in patients with hematological diseases worldwide. We aimed to investigate the...
7.
Qi P, Li P, Qiao L, Xue H, Ma Y, Wei S, et al.
J Chromatogr B Analyt Technol Biomed Life Sci
. 2023 May;
1224:123754.
PMID: 37229818
Pirarubicin (THP), doxorubicin (DOX), cyclophosphamide (CTX), and vincristine (VCR) are widely used in the treatment of patients with non-Hodgkin's Lymphoma. Herein, a precise and sensitive method was developed for the...
8.
He S, Mu H
Pharmaceutics
. 2023 Feb;
15(2).
PMID: 36839959
Many drug candidates are poorly water-soluble. Microenvironmental pH (pH) modification in buccal/sublingual dosage forms has attracted increasing interest as a promising pharmaceutical strategy to enhance the oral mucosal absorption of...
9.
Lu X, Liu W, Zhang L, Chen X, Yang L, Yao Q, et al.
Front Microbiol
. 2023 Feb;
14:1114972.
PMID: 36778870
Introduction: This research explored the clinical application of grade ≥ 3 infection predictive models for the newly diagnosed multiple myeloma (NDMM) population. Methods: It evaluated 306 patients with NDMM based...
10.
Zhang Y, Wang C, Liu G, Liang A, Zhao L, Huang J, et al.
Sci Bull (Beijing)
. 2023 Jan;
62(13):950-956.
PMID: 36659466
The ongoing discoveries and studies of novel topological quantum materials have become an emergent and important field of condensed matter physics. Recently, HfTe ignited renewed interest as a candidate of...